Kathryn Sangster
- Co-authors
- R. A. HawkinsMark J. ArendsStephen J. WigmoreKenneth C.H. FearonJean MaingayDavid A. FerenbachElodie MohrChristopher Bellamy
- Topics
- Estrogen and related hormone effects (9 papers)Effects and risks of endocrine disrupting chemicals (4 papers)Breast Cancer Treatment Studies (3 papers)
- Cited by
- Cancer ResearchOncologyBiochemistry
- Partner nations
- United KingdomCanadaAustralia
In The Last Decade
Kathryn Sangster
25 papers receiving 747 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 279
- Oncology 225
- Cancer Research 192
- Genetics 155
- Physiology 130
Countries citing papers authored by Kathryn Sangster
This map shows the geographic impact of Kathryn Sangster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Sangster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Sangster more than expected).
Fields of papers citing papers by Kathryn Sangster
This network shows the impact of papers produced by Kathryn Sangster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Sangster. The network helps show where Kathryn Sangster may publish in the future.
Co-authorship network of co-authors of Kathryn Sangster
This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Sangster. A scholar is included among the top collaborators of Kathryn Sangster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Sangster. Kathryn Sangster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 38 | |
| 2 | 45 | |
| 3 | 118 | |
| 4 | 3 | |
| 5 | 41 | |
| 6 | 11 | |
| 7 | 22 | |
| 8 | 91 | |
| 9 | 7 | |
| 10 | 128 | |
| 11 | 7 | |
| 12 | 3 | |
| 13 | 40 | |
| 14 | 10 | |
| 15 | 33 | |
| 16 | 8 | |
| 17 | 1 | |
| 18 | 9 | |
| 19 | 50 | |
| 20 | 2 |
About Kathryn Sangster
Kathryn Sangster is a scholar working on Cancer Research, Biochemistry and Genetics, having authored 26 papers that have together received 766 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (9 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Cancer Research (192 citations), Oncology (225 citations) and Biochemistry (44 citations). Kathryn Sangster has collaborated with scholars based in United Kingdom, Canada and Australia. Frequent co-authors include R. A. Hawkins, Mark J. Arends, Stephen J. Wigmore, Kenneth C.H. Fearon, Jean Maingay, David A. Ferenbach, Elodie Mohr, Christopher Bellamy, James A. Ross and Luke Devey. Their work appears in journals such as Cancer, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.